BRPI0718592A2 - compostos heterocíclicos bicíclicos substituidos por 4-cianofenilamino como inibidores de hiv - Google Patents

compostos heterocíclicos bicíclicos substituidos por 4-cianofenilamino como inibidores de hiv

Info

Publication number
BRPI0718592A2
BRPI0718592A2 BRPI0718592A BRPI0718592A BRPI0718592A2 BR PI0718592 A2 BRPI0718592 A2 BR PI0718592A2 BR PI0718592 A BRPI0718592 A BR PI0718592A BR PI0718592 A BRPI0718592 A BR PI0718592A BR PI0718592 A2 BRPI0718592 A2 BR PI0718592A2
Authority
BR
Brazil
Prior art keywords
cyanophenylamino
heterocyclic compounds
bicyclic heterocyclic
substituted bicyclic
hiv inhibitors
Prior art date
Application number
BRPI0718592A
Other languages
English (en)
Inventor
Girardet Jean-Luc
Shaw Stephanie
Koh Yung-Hyo
Hong Zhi
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of BRPI0718592A2 publication Critical patent/BRPI0718592A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0718592A 2006-11-09 2007-11-09 compostos heterocíclicos bicíclicos substituidos por 4-cianofenilamino como inibidores de hiv BRPI0718592A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85808206P 2006-11-09 2006-11-09
PCT/US2007/084342 WO2008058285A2 (en) 2006-11-09 2007-11-09 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors

Publications (1)

Publication Number Publication Date
BRPI0718592A2 true BRPI0718592A2 (pt) 2017-06-06

Family

ID=39365405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718592A BRPI0718592A2 (pt) 2006-11-09 2007-11-09 compostos heterocíclicos bicíclicos substituidos por 4-cianofenilamino como inibidores de hiv

Country Status (6)

Country Link
US (3) US7595324B2 (pt)
EP (1) EP2132211A4 (pt)
BR (1) BRPI0718592A2 (pt)
CA (1) CA2668997C (pt)
MX (1) MX2009005009A (pt)
WO (1) WO2008058285A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0313747A (pt) * 2002-08-23 2005-06-21 Ribapharm Inc Inibidores de transcriptase reversa de não-nucleosìdeo
US20060229305A1 (en) * 2005-03-22 2006-10-12 Markus Berger Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7595324B2 (en) * 2006-11-09 2009-09-29 Ardea Biosciences, Inc. Substituted thieno[3,2-D]pyrimidines as HIV inhibitors
EP2214675B1 (en) * 2007-10-25 2013-11-20 Genentech, Inc. Process for making thienopyrimidine compounds
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
KR101094446B1 (ko) * 2009-11-19 2011-12-15 한국과학기술연구원 단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
CN103517990A (zh) 2010-10-07 2014-01-15 通用医疗公司 癌症生物标志物
BR112013011737A2 (pt) 2010-11-15 2016-08-09 Univ Leuven Kath composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
EP2663312B1 (en) 2011-01-10 2017-10-11 Nimbus Iris, Inc. Irak inhibitors and uses thereof
CN104582705A (zh) 2012-01-10 2015-04-29 林伯士艾瑞斯公司 白介素-1受体相关激酶(irak)抑制剂和其用途
CN104902959A (zh) 2012-07-11 2015-09-09 林伯士艾瑞斯公司 Irak抑制剂和其用途
HK1210696A1 (en) 2012-07-11 2016-05-06 Nimbus Iris, Inc. Irak inhibitors and uses thereof
WO2014110114A1 (en) 2013-01-10 2014-07-17 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN103242341B (zh) * 2013-04-19 2015-12-09 中国科学院广州生物医药与健康研究院 噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
WO2015048281A1 (en) 2013-09-27 2015-04-02 Nimbus Iris, Inc. Irak inhibitors and uses thereof
EP3760208B1 (en) 2014-06-25 2024-05-29 The General Hospital Corporation Targeting human satellite ii (hsatii)
CN104926829A (zh) * 2015-06-08 2015-09-23 山东大学 一种噻吩并嘧啶类衍生物及其制备方法和应用
CN106831814B (zh) * 2017-02-15 2018-11-23 山东大学 一种噻吩并[3,2-d]嘧啶类HIV-1逆转录酶抑制剂及其制备方法和应用
CN106866699B (zh) * 2017-03-29 2019-03-08 山东大学 一种二芳基噻吩并嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用
CN109206435B (zh) * 2017-06-29 2020-09-08 中国医药研究开发中心有限公司 噻吩并[3,2-d]嘧啶类化合物及其制备方法和医药用途
US20210213041A1 (en) 2018-02-06 2021-07-15 The General Hospital Corporation Repeat rna as biomarkers of tumor immune response
CN108440559B (zh) * 2018-04-12 2020-06-16 山东大学 二芳基噻吩并嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用
CN114853781B (zh) * 2022-06-06 2023-09-08 山东大学苏州研究院 一种hiv-1逆转录酶靶向共价抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280026A (en) * 1989-05-30 1994-01-18 Smithkline Beecham Intercredit B.V. Thienopyrimidines
ES2361146T3 (es) 1998-03-27 2011-06-14 Janssen Pharmaceutica Nv Derivados de la piramidina inhibitatoria de vih.
DK1129096T3 (da) 1998-11-12 2003-09-15 Neurocrine Biosciences Inc CRF-receptorantagonister og fremgangsmåder, der er relateret dertil
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
JP4505228B2 (ja) * 2002-01-10 2010-07-21 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト Ｒｈｏ−キナーゼ阻害剤
PL227577B1 (pl) 2003-02-07 2017-12-29 Janssen Pharmaceutica Nv Zastosowanie pochodnych pirymidyny do wytwarzania leku do zapobiegania zakażeniu wirusem HIV oraz kompozycja farmaceutyczna
AP2006003517A0 (en) * 2003-09-25 2006-02-28 Janssen Pharmaceutica Nv Hiv replication purine derivatives.
US7595324B2 (en) * 2006-11-09 2009-09-29 Ardea Biosciences, Inc. Substituted thieno[3,2-D]pyrimidines as HIV inhibitors

Also Published As

Publication number Publication date
CA2668997A1 (en) 2008-05-15
EP2132211A4 (en) 2011-12-07
CA2668997C (en) 2012-10-09
MX2009005009A (es) 2009-09-22
US7595324B2 (en) 2009-09-29
US8211898B2 (en) 2012-07-03
WO2008058285A3 (en) 2009-04-09
US20090281124A1 (en) 2009-11-12
EP2132211A2 (en) 2009-12-16
US20080176871A1 (en) 2008-07-24
WO2008058285A2 (en) 2008-05-15
US20120225894A1 (en) 2012-09-06
US8324223B2 (en) 2012-12-04

Similar Documents

Publication Publication Date Title
FR20C1032I2 (fr) Inhibiteurs de beta-lactamase
EP2132211A4 (en) 4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER
BRPI0814426A2 (pt) Compostos heterocíclicos úteis como inibidores de mk2
BRPI0718266A2 (pt) Compostos heterocíclicos como agentes anti-inflamatórios.
BRPI0916233A2 (pt) compostos heterocíclicos antivirais
BRPI0809974A2 (pt) Compostos de pirimidina hidrazida como inibidores de pgds
BRPI0812825A2 (pt) Derivados ftalazinona como inibidores de parp-1
BRPI0920135A2 (pt) imidazopiridazinacarbonitrilos úteis como inibidores de quinase
ATE539070T1 (de) Heterozyklische antivirale verbindungen
BRPI0906625A2 (pt) Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace)
BRPI1016189A2 (pt) compostos de 4-azetidinil-1-fenil-ciclohexano antagonistas de ccr2
BRPI0913879A2 (pt) fenilpirazinonas como inibidores de quinase
BRPI0811065A2 (pt) Indazóis 5-heteroaril substituídos como inibidores de quinase
BRPI0918045A2 (pt) compostos de carboxamida heterocíclicos
BR112012005616A2 (pt) compostos antivirais heterocíclicos
BRPI0718509A2 (pt) compostos orgânicos heterocíclicos
BRPI1010852A2 (pt) compostos antivirais heterocíclicos
EP2192838A4 (en) HETEROCYCLIC NEKROPTOSIS HEMMER
DE602008003015D1 (de) Heterocyclische spiroverbindungen
BRPI0920239A2 (pt) compostos heterocíclicos como inibidores de proteínas quinases
BRPI0906705A2 (pt) Composto heterocíclicos
BRPI0912475A8 (pt) compostos como inibidores de quinase
BRPI0813768A2 (pt) Derivados de benzazepina úteis como antagonistas de vasopressina
BRPI0821349A2 (pt) compostos antivirais heterocíclicos
BRPI0815948A2 (pt) "compostos heterocíclicos como antagonistas de receptorncrth2"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]